Cargando…

Cost-effectiveness analysis of flucytosine as induction therapy in the treatment of cryptococcal meningitis in HIV-infected adults in South Africa

BACKGROUND: Cryptococcal meningitis in HIV-infected patients in sub-Saharan Africa accounts for three-quarters of the global cases and 135,000 deaths per annum. Current treatment includes the use of fluconazole and amphotericin B. Recent evidence has shown that the synergistic use of flucytosine imp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miot, Jacqui, Leong, Trudy, Takuva, Simbarashe, Parrish, Andrew, Dawood, Halima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025344/ https://www.ncbi.nlm.nih.gov/pubmed/33823842 http://dx.doi.org/10.1186/s12913-021-06268-9

Ejemplares similares

Addition of Flucytosine to Fluconazole for the Treatment of Cryptococcal Meningitis in Africa: A Multicountry Cost-effectiveness Analysis
por: Shiri, Tinevimbo, et al.
Publicado: (2020)

Induction therapy with high‐dose fluconazole plus flucytosine for human immunodeficiency virus‐uninfected cryptococcal meningitis patients: Feasible or not?
por: Zhao, Hua‐Zhen, et al.
Publicado: (2022)

Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV-associated cryptococcal meningitis: a prospective multicenter study in China
por: Zhao, Ting, et al.
Publicado: (2022)

Prevalence and Hospital Management of Amphotericin B Deoxycholate-Related Toxicities during Treatment of HIV-Associated Cryptococcal Meningitis in South Africa
por: Meiring, Susan, et al.
Publicado: (2016)

Cost Effectiveness of Cryptococcal Antigen Screening as a Strategy to Prevent HIV-Associated Cryptococcal Meningitis in South Africa
por: Jarvis, Joseph N., et al.
Publicado: (2013)

Population pharmacokinetics and CSF penetration of flucytosine in adults with HIV-associated cryptococcal meningoencephalitis
por: Stott, Katharine E, et al.
Publicado: (2023)

Fluconazole plus flucytosine is a good alternative therapy for non‐HIV and non‐transplant‐associated cryptococcal meningitis: A retrospective cohort study
por: Li, Zhanyi, et al.
Publicado: (2019)

Treatment of Cryptococcal Meningitis in KwaZulu-Natal, South Africa
por: Lightowler, Josephine V. J., et al.
Publicado: (2010)

Pathways to care and outcomes among hospitalised HIV-seropositive persons with cryptococcal meningitis in South Africa
por: Quan, Vanessa, et al.
Publicado: (2019)

Healthcare Costs and Life-years Gained From Treatments Within the Advancing Cryptococcal Meningitis Treatment for Africa (ACTA) Trial on Cryptococcal Meningitis: A Comparison of Antifungal Induction Strategies in Sub-Saharan Africa
por: Chen, Tao, et al.
Publicado: (2019)

Induction-phase treatment costs for cryptococcal meningitis in high HIV-burden African countries: New opportunities with lower costs
por: Larson, Bruce, et al.
Publicado: (2022)

Incidence and predictors of recovery from anaemia within an HIV-infected South African Cohort, 2004-2010
por: Ndlovu, Zibusiso, et al.
Publicado: (2014)

Treatment for HIV‐associated cryptococcal meningitis
por: Tenforde, Mark W, et al.
Publicado: (2018)

Fungal CNS Infections in Africa: The Neuroimmunology of Cryptococcal Meningitis
por: Mohamed, Sally H., et al.
Publicado: (2022)

One-year Mortality Outcomes From the Advancing Cryptococcal Meningitis Treatment for Africa Trial of Cryptococcal Meningitis Treatment in Malawi
por: Kanyama, Cecilia, et al.
Publicado: (2020)

Understanding the costs and the cost structure of a community-based HIV and gender-based violence (GBV) prevention program: the Woza Asibonisane Community Responses Program in South Africa
por: Larson, Bruce, et al.
Publicado: (2020)

Ventriculoperitoneal shunts in non-HIV cryptococcal meningitis
por: Liu, Jia, et al.
Publicado: (2018)

Cryptococcal Meningitis in a HIV-Negative Patient
por: Barreiros, Cátia, et al.
Publicado: (2018)

Immune correlates of HIV-associated cryptococcal meningitis
por: Tenforde, Mark W., et al.
Publicado: (2017)

Cryptococcal Meningitis in an HIV-Negative Puerperal Woman
por: Robalo Nunes, Tomás, et al.
Publicado: (2021)

Anemia among HIV-Infected Patients Initiating Antiretroviral Therapy in South Africa: Improvement in Hemoglobin regardless of Degree of Immunosuppression and the Initiating ART Regimen
por: Takuva, Simbarashe, et al.
Publicado: (2013)

Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal Meningitis
por: Bicanic, Tihana, et al.
Publicado: (2015)

Flucytosine and its clinical usage
por: Sigera, L. Shamithra M., et al.
Publicado: (2023)

Risk factors in HIV/AIDS patients with cryptococcal meningitis
por: Bădicuț, Ioana, et al.
Publicado: (2014)

Paradoxical Immune Responses in Non-HIV Cryptococcal Meningitis
por: Panackal, Anil A., et al.
Publicado: (2015)

1593 Predictors of Mortality for HIV-associated Cryptococcal Meningitis
por: Nimitvilai, Sireethorn, et al.
Publicado: (2014)

Recent advances in managing HIV-associated cryptococcal meningitis
por: Boyer-Chammard, Timothée, et al.
Publicado: (2019)

Short-Course Rather Than Low-Dose Amphotericin B May Exert Potential Influence on Mortality in Cryptococcal Meningitis Patients Treated With Amphotericin B Plus Flucytosine Alone or in Combination With Fluconazole
por: Xu, Lijun, et al.
Publicado: (2019)

Cryptococcal Meningitis and Tuberculous Meningitis Co-infection in HIV-Infected Ugandan Adults
por: Ellis, Jayne, et al.
Publicado: (2018)

Ambulatory induction phase treatment of cryptococcal meningitis in HIV integrated primary care clinics, Yangon, Myanmar
por: Warrell, Clare E., et al.
Publicado: (2021)

Cost-effectiveness of CRAG-LFA screening for cryptococcal meningitis among people living with HIV in Uganda
por: Ramachandran, Anu, et al.
Publicado: (2017)

Cost-effectiveness of reflex laboratory-based cryptococcal antigen screening for the prevention and treatment of cryptococcal meningitis in Botswana
por: Tenforde, Mark W., et al.
Publicado: (2020)

Hyponatremia as a Predictor of Cryptococcal Meningitis and Death Among Asymptomatic Persons With HIV and Cryptococcal Antigenemia
por: Lehman, Alice, et al.
Publicado: (2023)

Reduction in initiations of HIV treatment in South Africa during the COVID pandemic
por: Benade, Mariet, et al.
Publicado: (2022)

Volunteering, health and the homeless – the cost of establishing a student-run primary healthcare clinic serving the inner-city homeless in South Africa
por: Johnston, Deanne, et al.
Publicado: (2020)

Nosocomial Drug-Resistant Bacteremia in 2 Cohorts with Cryptococcal Meningitis, Africa
por: Rajasingham, Radha, et al.
Publicado: (2014)

Molecular mechanisms of cryptococcal meningitis
por: Liu, Tong-Bao, et al.
Publicado: (2012)

Cryptococcal meningitis complicating sarcoidosis
por: Leonhard, Sonja E., et al.
Publicado: (2016)

Kinetics of HIV-1 in cerebrospinal fluid and plasma in cryptococcal meningitis
por: Cecchini, Diego M., et al.
Publicado: (2012)

Noninvasive intracranial pressure monitoring for HIV-associated cryptococcal meningitis
por: Bollela, V.R., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0g1c72ro7qi5f91il5tu5f1cof